Visine Novo eye drops

Visine is one of the most recognized global brands for eye care, specifically formulated to relieve eye redness and minor irritations. The 'Novo' variant shown in the image is marketed in Romania and contains tetryzoline hydrochloride, a decongestant that constricts blood vessels in the eye to reduce redness.

Originally developed in the United States, the brand has been a staple in medicine cabinets for decades. It was a long-time flagship brand of Pfizer's consumer healthcare division before being acquired by Johnson & Johnson. In 2023, Johnson & Johnson completed the spin-off of its consumer health business into a new independent company called Kenvue.

Today, Visine is an integral part of the Kenvue portfolio. While the brand has American roots, manufacturing for the European market often takes place in specialized pharmaceutical facilities in Italy and France to meet local regulatory standards and ensure a steady supply chain across the continent.